Roman Butler Fullerton & Co. Trims Holdings in Cigna Group $CI

Roman Butler Fullerton & Co. trimmed its position in shares of Cigna Group (NYSE:CI) by 19.8% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,455 shares of the health services provider’s stock after selling 3,318 shares during the period. Cigna Group makes up about 1.0% of Roman Butler Fullerton & Co.’s holdings, making the stock its 24th largest holding. Roman Butler Fullerton & Co.’s holdings in Cigna Group were worth $4,097,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Norges Bank purchased a new position in Cigna Group in the fourth quarter valued at $1,019,790,000. Northwestern Mutual Wealth Management Co. lifted its position in Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after acquiring an additional 3,141,844 shares during the last quarter. Dodge & Cox boosted its stake in Cigna Group by 19.7% in the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares in the last quarter. Boston Partners grew its holdings in shares of Cigna Group by 314.6% during the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after purchasing an additional 1,243,056 shares during the last quarter. Finally, GQG Partners LLC grew its holdings in shares of Cigna Group by 14.3% during the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after purchasing an additional 972,302 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

CI opened at $282.24 on Monday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The stock has a market cap of $74.58 billion, a P/E ratio of 11.68, a P/E/G ratio of 0.97 and a beta of 0.29. The stock’s 50 day simple moving average is $286.02 and its 200 day simple moving average is $281.28. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same quarter last year, the company earned $7.20 earnings per share. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 25.82%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CI. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and reduced their target price for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Wells Fargo & Company lifted their price target on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Barclays boosted their price objective on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. UBS Group raised their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Finally, Piper Sandler cut their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Insider Activity at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.